OBJECTIVE:
METHODS:
RESULTS:
CONCLUSION:
Geographical regions | N | HCV-HIV prevalence (Anti-HCV) | References |
---|---|---|---|
Florianópolis, SC | 99 | 53.8% | Treitinger et al., 199934 |
São Paulo, SP | 1,457 | 17.7% | Mendes-Corrêa et al., 200141 |
Rio de Janeiro, RJ | 238 | 8.9% | Ferraz et al., 200242 |
Campinas, SP | 232 | 53.8% | Pavan et al., 200335 |
Santos, SP | 495 | 36.2% | Segurado et al., 200421 |
Londrina, PR | 784 | 21.0% | Morimoto et al., 200522 |
Manaus, AM | 704 | 5.0% | Braga et al., 200623 |
Porto Alegre, RS | 330 | 38.2% | Tovo et al., 200625 |
Cuiabá, MT | 1,008 | 10.9% | Mussi et al., 200726 |
Botucatu, SP | 150 | 14.7% | Corvino et al., 200743 |
Belo Horizonte, MG | 824 | 9.2% | Carmo et al., 200844 |
Belo Horizonte, MG | 300 | 15.7% | Rodrigues et al., 200845 |
Londrina, PR | 778 | 21.0% | Reiche et al., 200829 |
São Paulo, SP | 8,019 | 12.9% | Farias et al., 200828 |
Recife, PE | 343 | 4.1% | Carvalho et al., 200946 |
São Paulo, SP | 2,024 | 16.7% | Mendes-Corrêa et al., 201040 |
Santa Maria, RS | 250 | 31.2% | Santos et al., 201030 |
CE | 1,291 | 25.4% | Távora et al., 201332 |
Curitiba, PR | 303 | 12.9% |
Full article at: http://goo.gl/LlHsVX
By: Tizzot MR1, Grisbach
C2, Beltrame
MH3, Messias-Reason
IJ4.
1Pharmacy Course, UNIBRASIL, Curitiba, PR, Brazil.
2Universidade Federal do paraná, Curitiba, PR, Brazil.
3Hospital das Clínicas, UFPR, Curitiba, PR, Brazil.
4Pathology Department, UFPR, Curitiba, PR, Brazil.
Rev Assoc Med Bras. 2016
Feb;62(1):65-71. doi: 10.1590/1806-9282.62.01.65.
More at: https://twitter.com/hiv insight
No comments:
Post a Comment